Ledger.Open graph →
SEC Form D · filed September 2, 2015

Audentes Therapeutics, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Thomas Schuetz · San Francisco, CADirectorThomas Woiwode · Menlo Park, CADirectorSteven Waldman · Brooklyn, NYExec · DirectorCraig Kaplan · Capitola, CAExec · DirectorR. C. Pica · San Bruno, CADirectorJustis G. Kao · Studio City, CADirectorMatthew Patterson · San Francisco, CAExec · DirectorEd Neas · Fort Collins, CODirectorKush Parmar · Menlo Park, CADirectorJonathan Leff · New York, NYDirectorRichard P. Fox · Rochester, NYDirectorSteve Squinto · San Francisco, CADirectorLouis G. Lange · San Francisco, CADirectorThomas Woiwode · Menlo Park, CADirectorDaniel R. Omstead · San Diego, CADirectorJonathan Silverstein · New York, NYDirectorRoy Carver, Jr · Fort Collins, CODirectorTomas N. Tejero · Mexico DF, O5DirectorWilliam Nelson, V · Fort Collins, CODirectorBenjamin Capell · Salt Lake City, UTDirectorSong Yi · Metairie, LADirectorElai R. Davicioni · San Diego, CADirectorDoug C. Pica · San Bruno, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗